http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5994528-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 1998-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e261f1de27793745569d0f02229a707 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7007d611c0f8270cf7fa957d3afacde3 |
| publicationDate | 1999-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5994528-A |
| titleOfInvention | Method of detecting gene expression and/or of preventing such expression in cells |
| abstract | A method of amplifying a nucleotide sequence complementary to an mRNA template derived from genomic DNA. The method involves the following steps. A sample mixture containing an mRNA template and corresponding genomic DNA is provided, the genomic DNA including at least two exons separated by at least one intron. A pair of intron-blockers are introduced into the mixture, the intron-blockers comprising a sequence of intron-specific oligonucleotides modified to prevent nucleotide extension in conditions promoting polymerase chain reaction. A primer pair promoting amplification of cDNA derived from the mRNA template is introduced into the mixture and then reverse transcription polymerase chain reaction is carried out to amplify cDNA. Detection of the cDNA is proof of the existence of mRNA in the sample, and thus proof of expression of the corresponding gene. The method avoids false positives caused by amplification of genomic DNA as well as cDNA based on an mRNA template. The invention includes a method of suppressing gene expression in vivo, which comprises exposing cells containing a gene to be suppressed, made up of exons and at least one intron, to intron-blockers having nucleotide sequences that bind to the intron to prevent gene expression. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785130-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0113086-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006228307-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003022231-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9150906-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0113086-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007072212-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005002975-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008003573-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10036053-B2 |
| priorityDate | 1996-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 141.